BioPorto Logo.png
Strong Performance of The NGAL Test Drives Revenue Growth
May 11, 2022 02:59 ET | BioPorto A/S
May 11, 2022Announcement no. 11 Strong Performance of The NGAL Test Drives Revenue Growth Revenues totaled DKK 6.5 million in the first quarter of 2022, a 17% increase over the prior year. This...
BioPorto Logo.png
Grant of warrants
May 05, 2022 14:17 ET | BioPorto A/S
May 5, 2022Announcement no. 10 Grant of warrants The Board of Directors of BioPorto A/S (“BioPorto”) (Nasdaq: BIOPOR), in accordance with its current authorization to issue warrants to key employees...
BioPorto Logo.png
BioPorto A/S - Annual General Meeting
April 28, 2022 08:49 ET | BioPorto A/S
April 28, 2022Announcement no. 9 BioPorto A/S - Annual General Meeting Today, BioPorto A/S held its Annual General Meeting. The general meeting resolved to conduct the meeting in English without...
BioPorto Logo.png
Notice Convening the Annual General Meeting
April 06, 2022 05:24 ET | BioPorto A/S
April 6, 2022 Announcement no. 8         NOTICE CONVENING THE ANNUAL GENERAL MEETING The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S (the “Company”): April 28,...
BioPorto Logo.png
BioPorto Publishes 2021 Annual Report  
April 06, 2022 04:27 ET | BioPorto A/S
April 6, 2022Announcement no. 7 BioPorto Publishes 2021 Annual Report BioPorto A/S (BioPorto), an in vitro diagnostics company focused on saving lives and improving the quality of life with...
BioPorto Logo.png
Managers’ transactions
April 01, 2022 01:35 ET | BioPorto A/S
April 1, 2022Announcement no. 6 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in company announcement no. 4, BioPorto A/S has received...
BioPorto Logo.png
Major Shareholder Announcement
April 01, 2022 01:25 ET | BioPorto A/S
April 1, 2022Announcement no. 5 Major Shareholder Announcement BioPorto A/S hereby announces the receipt of a notification pursuant to section 38(1) of the Danish Capital Markets Act from...
BioPorto Logo.png
BioPorto A/S announces completion of rights issue; capital raised, total number of shares, and voting rights
April 01, 2022 01:15 ET | BioPorto A/S
April 1, 2022Announcement no. 4 This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States,...
BioPorto Logo.png
BioPorto A/S announces results of rights issue – Offering fully subscribed
March 28, 2022 06:11 ET | BioPorto A/S
March 28, 2022Announcement no. 3 This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada,...
BioPorto Logo.png
BioPorto A/S publishes prospectus in connection with a rights issue with pre-emptive subscription rights for its existing shareholders
March 07, 2022 09:23 ET | BioPorto A/S
March 7, 2022Announcement no. 2 This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada,...